Fertility Services Market: Market Size & Forecast 2026

The fertility services market includes a wide range of medical interventions and supportive services aimed at addressing difficulties in conceiving, with in vitro fertilization (IVF) remaining the largest and most widely recognized procedure. The market also covers ovulation induction, intrauterine insemination (IUI), fertility preservation (egg and sperm freezing), surrogacy arrangements, and donor egg and sperm programs. While market size estimates vary across sources due to differing scope definitions, the sector as a whole is broadly valued between $33 billion and $52 billion in 2025, with an average midpoint near $42 billion.

• •IVF cycles represent the single largest revenue contributor within the market, with over 500,000 cycles performed globally each year
• •The closely related assisted reproductive technology (ART) segment alone is valued at approximately $4.29 billion in 2025
• •Fertility clinics, hospitals, and specialized reproductive centers form the primary service delivery channels

One of the strongest structural drivers of market growth is the rising age at which people attempt to conceive, as female fertility declines significantly after the mid-30s and male sperm quality also decreases with age. Globally, the World Health Organization estimates that roughly one in six people of reproductive age experience infertility over their lifetime. Wider acceptance and adoption of assisted reproductive technologies, combined with declining costs of genetic screening and improved clinical success rates, have expanded the eligible patient population considerably.

• •Nearly 18% of women aged 18-49 in the United States alone have used fertility services or sought medical help to conceive
• •Male factor infertility accounts for approximately 40-50% of all infertility cases, increasing demand for treatments involving intracytoplasmic sperm injection (ICSI) and surgical sperm retrieval
• •Policies expanding insurance coverage for fertility treatments, including IVF mandates in several U.S. states and growing support in European nations, have reduced out-of-pocket costs for patients

By procedure type, the market is generally segmented into IVF/non-IVF treatments, with IVF accounting for the majority share due to its effectiveness for a broad range of infertility diagnoses. Fertility preservation and diagnostics are among the fastest-growing sub-segments. Geographically, North America leads in revenue, supported by advanced healthcare infrastructure, favorable reimbursement policies, and high awareness levels. Europe follows closely, with countries such as Spain, Germany, and the United Kingdom maintaining strong IVF program volumes.

• •Asia-Pacific is projected to register the highest growth rate, driven by medical tourism in countries like India, Thailand, and Turkey, combined with rising domestic demand in China and Japan
• •The Middle East, Africa, and Latin America represent smaller but emerging markets, with countries including the UAE, Mexico, and Brazil investing in specialized fertility clinic infrastructure
• •South Korea and Taiwan have among the lowest fertility rates globally, with some of the highest per-capita utilization rates of assisted reproductive technology in Asia

What are the recent trends and outlook?

Emerging technologies are reshaping how fertility clinics deliver care, with artificial intelligence being applied to embryo selection, sperm analysis, and hormone cycle monitoring to improve success rates and reduce variability between clinics. Growing awareness and demand for fertility preservation among cancer patients and those choosing to delay childbearing are expanding the social egg-freezing and fertility preservation market. Regulatory landscapes continue to evolve, with several jurisdictions reviewing and updating guidelines around embryo research, donor anonymity, and cross-border reproductive care.

• •Egg freezing has seen a sharp increase in uptake, with the number of elective oocyte cryopreservation cycles rising significantly in major markets over the past five years
• •Non-invasive embryo testing and time-lapse imaging systems are increasingly replacing traditional biopsy methods as clinic standard practices
• •Telemedicine and digital health platforms are being integrated into fertility care workflows for remote monitoring, medication management, and patient education